Effects of Intravitreal Ranibizumab Injection on Chinese Patients with Wet Age-Related Macular Degeneration: 5-Year Follow-Up Results

Table 1

Visual acuity gain or loss at the 5th year after treatment.

Visual acuity; ETDRS	VA at the 5th year after treatment; (), %
Gain ≥ 15 letters	5 (13.5%)
Gain within 15 letters	9 (24.3%)
Loss within 15 letters	10 (27.0%)
Loss ≥ 15 letters	13 (35.1%)